- Home
- GNSS vs ALEC Comparison
GNSS vs ALEC Comparison
Compare GNSS & ALEC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GNSS
- ALEC
- Stock Information
- Founded
- GNSS 1992
- ALEC 2013
- Country
- GNSS United States
- ALEC United States
- Employees
- GNSS N/A
- ALEC N/A
- Industry
- GNSS Consumer Electronics/Appliances
- ALEC Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- GNSS Consumer Staples
- ALEC Health Care
- Exchange
- GNSS Nasdaq
- ALEC Nasdaq
- Market Cap
- GNSS 112.9M
- ALEC 124.0M
- IPO Year
- GNSS N/A
- ALEC 2019
- Fundamental
- Price
- GNSS $2.34
- ALEC $1.47
- Analyst Decision
- GNSS Strong Buy
- ALEC Hold
- Analyst Count
- GNSS 1
- ALEC 9
- Target Price
- GNSS $5.75
- ALEC $3.40
- AVG Volume (30 Days)
- GNSS 135.0K
- ALEC 5.1M
- Earning Date
- GNSS 12-08-2025
- ALEC 11-06-2025
- Dividend Yield
- GNSS N/A
- ALEC N/A
- EPS Growth
- GNSS N/A
- ALEC N/A
- EPS
- GNSS N/A
- ALEC N/A
- Revenue
- GNSS $30,470,000.00
- ALEC $81,130,000.00
- Revenue This Year
- GNSS $85.24
- ALEC N/A
- Revenue Next Year
- GNSS $78.33
- ALEC $290.64
- P/E Ratio
- GNSS N/A
- ALEC N/A
- Revenue Growth
- GNSS 8.95
- ALEC 46.77
- 52 Week Low
- GNSS $1.46
- ALEC $0.87
- 52 Week High
- GNSS $4.04
- ALEC $6.14
- Technical
- Relative Strength Index (RSI)
- GNSS 58.12
- ALEC 27.42
- Support Level
- GNSS $2.10
- ALEC $1.45
- Resistance Level
- GNSS $2.29
- ALEC $1.68
- Average True Range (ATR)
- GNSS 0.11
- ALEC 0.21
- MACD
- GNSS 0.01
- ALEC -0.15
- Stochastic Oscillator
- GNSS 80.65
- ALEC 6.76
About GNSS Genasys Inc.
Genasys Inc is a provider of Protective Communication solutions, including Genasys Protect software platform and Long Range Acoustic Device (LRAD). Its software platform receives information from variety of sensors and Internet-of-Things (IoT) inputs to collect real-time information on developing and active emergency situations. Genasys uses this information to create and disseminate alerts, warnings, notifications, and instructions through multiple channels before, during, and after public safety and enterprise threats, critical events, and other crisis situations. The Company operates in two business segments: Hardware and Software and its markets are North and South America, Europe, Middle East and Asia. Key revenue is generated from Hardware.
About ALEC Alector Inc.
Alector Inc is a clinical-stage biopharmaceutical company. It is engaged in developing a novel therapeutic approach for the treatment of neurodegeneration. The firm is involved in developing therapies that are designed to simultaneously counteract pathologies by restoring healthy immune function to the brain. Its pipeline products include AL001, AL002, AL003, and AL101.